Why the study?
Does a centrifugal pump with a curved vane reduce platelet damage compared to a roller pump in patients undergoing elective CABG?
Does a centrifugal pump with a curved vane reduce platelet damage compared to a roller pump in patients undergoing elective CABG?
The use of a curved vane centrifugal pump during cardiopulmonary bypass for CABG reduces platelet activation compared to a standard roller pump.
Answers are grounded in this paper and cite their sources.
Curved-vane centrifugal pumps were associated with lower platelet activation during CABG on CPB; hypothesis-generating and requires randomized confirmation before practice change.
The centrifugal pump with the curved vane (Lifestream Centrifugal Pump [LCP]) was applied to cardiopulmonary bypass (CPB) in 10 patients who underwent elective coronary artery bypass grafting. Serum hemoglobin levels, platelet counts, and serum beta-thromboglogulin (beta-TG) levels were measured during CPB. The results were compared with those for a comparative roller pump (RP) group (n = 10). There was no difference in CPB time between LCP (112 +/- 22 min) and RP (121 +/- 22 min) groups. Serum beta-TG levels (ng/ml) were lower in the LCP group than in the RP group (34 +/- 9 vs. 101 +/- 80, 5 min; 81 +/- 33 vs. 236 +/- 112, 30 min; 120 +/- 53 vs. 314 +/- 100, 60 min after initiation of CPB; p < 0.05). There were no significant differences in hemolysis and platelet depletion. The LCP showed excellent hemodynamic performance with less blood trauma in clinical application to open heart surgery.
No takes yet. Share an insight, caveat, or question.
Nishinaka et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: